Sawai Usa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAWAI USA
SAWAI USA has four approved drugs.
Summary for Sawai Usa
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
| Patent Litigation for Sawai Usa: | See patent lawsuits for Sawai Usa |
| PTAB Cases with Sawai Usa as petitioner: | See PTAB cases with Sawai Usa as petitioner |
Drugs and US Patents for Sawai Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sawai Usa | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205955-002 | Feb 3, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sawai Usa | DIMETHYL FUMARATE | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 210285-001 | Dec 21, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sawai Usa | MIRABEGRON | mirabegron | TABLET, EXTENDED RELEASE;ORAL | 217061-001 | May 6, 2025 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sawai Usa | MIRABEGRON | mirabegron | TABLET, EXTENDED RELEASE;ORAL | 209446-001 | Dec 27, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sawai Usa | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205955-001 | Feb 3, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sawai Usa | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205955-003 | Feb 3, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sawai Usa | DIMETHYL FUMARATE | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 210285-002 | Dec 21, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
